However, we should not only focus on the straightforward disruption of the PD-1/PD-L1 suppression axis, it is considerable that strengthening the MHC non-restrictive immunity to supplement and strengthen anti-tumor immunity. This evidence concerns the gene CD274 and neoplasm.